Clinical data | |
---|---|
Other names | AKR-001; AMG-876 |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem SID | |
UNII |
Efruxifermin (AKR-001) is a fibroblast growth factor 21 (FGF21) analog developed to treat nonalcoholic steatohepatitis and type 2 diabetes. [1] [2] [3]
Clinical data | |
---|---|
Other names | AKR-001; AMG-876 |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem SID | |
UNII |
Efruxifermin (AKR-001) is a fibroblast growth factor 21 (FGF21) analog developed to treat nonalcoholic steatohepatitis and type 2 diabetes. [1] [2] [3]